Scot Harper
Chief Tech/Sci/R&D Officer chez RADIOPHARM THERANOSTICS LIMITED
Profil
Scot L.
Harper is currently the Senior Vice President-Clinical Operations at Radiopharm Theranostics Ltd.
Previously, he worked as the Vice President-Clinical Operations at Endocyte, Inc. from 2013 to 2016.
Harper received his undergraduate degree from DePauw University, his graduate degree from the University of South Alabama, and his doctorate from The Indiana University School of Medicine.
Postes actifs de Scot Harper
| Sociétés | Poste | Début |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Chief Tech/Sci/R&D Officer | 01/12/2021 |
Anciens postes connus de Scot Harper
| Sociétés | Poste | Fin |
|---|---|---|
| ENDOCYTE, INC. | Chief Tech/Sci/R&D Officer | 28/10/2016 |
Formation de Scot Harper
| DePauw University | Undergraduate Degree |
| University of South Alabama | Graduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Entreprise privées | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
